Page 100 - Haematologica - Vol. 105 n. 6 - June 2020

F. Stölzel et al.
References
1. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937-951.
2. Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011;118(14):3785-3793.
3. Avni B, Rund D, Levin M, et al. Clinical implications of acute myeloid leukemia pre- senting as myeloid sarcoma. Hematol Oncol. 2012;30(1):34-40.
4. Cornelissen JJ, Gratwohl A, Schlenk RF, et al. The European LeukemiaNet AML Working Party consensus statement on allo- geneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol. 2012;9(10):579-590.
5. Ganzel C, Manola J, Douer D, et al. Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008. J Clin Oncol. 2016;34(29):3544-3553.
6. Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424-447.
7. Karlin L, Itti E, Pautas C, et al. PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma. Haematologica.
2006;91(12 Suppl):ECR54.
8. Stolzel F, Rollig C, Radke J, et al. (1)(8)F-
FDG-PET/CT for detection of extramedullary acute myeloid leukemia. Haematologica. 2011;96(10):1552-1556.
9. Aschoff P, Hantschel M, Oksuz M, et al. Integrated FDG-PET/CT for detection, ther- apy monitoring and follow-up of granulo- cytic sarcoma. Initial results. Nuklearmedizin. 2009;48(5):185-191.
10. Kuenzle K, Taverna C, Steinert HC. Detection of extramedullary infiltrates in acute myelogenous leukemia with whole- body positron emission tomography and 2- deoxy-2-[18F]-fluoro-D-glucose. Mol Imaging Biol. 2002;4(2):179-183.
11. Makis W, Hickeson M, Derbekyan V. Myeloid sarcoma presenting as an anterior mediastinal mass invading the pericardium: Serial Imaging With F-18 FDG PET/CT. Clin Nucl Med. 2010;35(9):706-709.
12. Mantzarides M, Bonardel G, Fagot T, et al. Granulocytic sarcomas evaluated with F-18- fluorodeoxyglucose PET. Clin Nucl Med. 2008;33(2):115-117.
13. Ueda K, Ichikawa M, Takahashi M, Momose T, Ohtomo K, Kurokawa M. FDG- PET is effective in the detection of granulo- cytic sarcoma in patients with myeloid malignancy. Leukemia Res. 2010;34(9):1239- 1241.
14. Buck AK, Bommer M, Juweid ME, et al. First demonstration of leukemia imaging with the proliferation marker 18F-fluo- rodeoxythymidine. J Nucl Med. 2008;49(11):1756-1762.
15. Sekeres MA, Elson P, Kalaycio ME, et al. Time from diagnosis to treatment initiation predicts survival in younger, but not older,
acute myeloid leukemia patients. Blood.
2009;113(1):28-36.
16. Cheson BD, Bennett JM, Kopecky KJ, et al.
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003;21(24):4642-4649.
17. Cribe AS, Steenhof M, Marcher CW, Petersen H, Frederiksen H, Friis LS. Extramedullary disease in patients with acute myeloid leukemia assessed by 18F- FDG PET. Eur J Haematol. 2013;90(4):273- 278.
18. Liu PI, Ishimaru T, McGregor DH, Okada H, Steer A. Autopsy study of granulocytic sar- coma (chloroma) in patients with myeloge- nous leukemia, Hiroshima-Nagasaki 1949- 1969. Cancer. 1973;31(4):948-955.
19. Zhou WL, Wu HB, Wang LJ, Tian Y, Dong Y, Wang QS. Usefulness and pitfalls of F-18- FDG PET/CT for diagnosing extramedullary acute leukemia. Eur J Radiol. 2016;85(1):205- 210.
20. Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340-350.
21. O'Donnell MR, Tallman MS, Abboud CN, et al. Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2017;15(7):926-957.
22. Cunningham I, Kohno B. 18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases. Am J Hematol. 2016;91(4):379- 384.
1558
haematologica | 2020; 105(6)